what is cryptocurrency and how it works, See results about

Xinxiangwei: Shareholder Xinyu Yijiade intends to reduce its shareholding by no more than 1%. Xinxiangwei announced that as of the disclosure date, Shareholder Xinyu Yijiade holds 20,175,800 shares of the company, accounting for 4.39% of the company's total share capital. Xinyu Yijiade plans to reduce the number of shares of the company by no more than 4,595,300 shares through centralized bidding or block trading of Shanghai Stock Exchange within 90 days after 15 trading days from the date of announcement, and the proportion of reduced shares in the company's total share capital is no more than 1%.The EUR/USD of the euro against the US dollar rose by 0.50% in the day and is now reported at 1.0518.Two States in the United States sued Glock, a gun manufacturer, for ignoring the design flaw that "pistols can easily become machine guns". On the 12th, the prosecutors in New Jersey and Minnesota respectively sued Glock, an Austrian weapons manufacturer, accusing the pistol manufactured by them of design defects and being easily converted into illegal machine guns. According to the complaint, Glock knew this situation for a long time, and continued to sell this pistol to the United States and profit from it, which promoted the proliferation of gun violence in the United States. (Xinhua News Agency)

Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.GCL Technology: It is estimated that there will be no more share repurchase cancellation in 2024. GCL Technology (03800) announced that in view of the fact that the photovoltaic industry is still in excessive competition, in order to ensure the stability of the company's operation and cope with the uncertainty in the future, the company expects that there will be no more share repurchase cancellation in the year ending December 31, 2024.COMEX silver fell 2.00% in the day and is now quoted at $30.99 per ounce. COMEX silver fell to $31 per ounce, down 1.97% in the day.

The EUR/USD of the euro against the US dollar rose by 0.50% in the day and is now reported at 1.0518.Sources: Russia has suspended grain exports to Syria. Russian and Syrian sources said on Friday that Russia's wheat supply to Syria has been suspended due to the uncertainty of the new Syrian government and the delay in payment.Bei Ya raised Broadcom's target price from $195.00 to $210.00.